Get started Log in

ALNAQ — Allena Pharmaceuticals Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE
07/11/2019 14:32
Brief: Allena Pharmaceuticals Completes Enrollment In Pivotal Phase 3 Urirox-1 Trial Evaluating Reloxaliase In Patients With Enteric Hyperoxaluria
16/09/2019 13:47
U.S. RESEARCH ROUNDUP-3D Systems, G1 Therapeutics, Zillow Group
08/08/2019 08:33
Brief: Allena Pharmaceuticals Reports Q2 Loss Per Share $0.54
07/08/2019 13:12
Brief: Altium Capital Management LP Reports 9.98% Stake In Allena Pharmaceuticals Inc
02/07/2019 11:10
Brief: Allena Pharmaceuticals Announces $10.0 Million Registered Direct Offering Of Common Stock
28/06/2019 01:49
U.S. STOCKS ON THE MOVE-Apple, Navistar, Box, Mattel,
04/06/2019 15:56
Brief: Allena Pharmaceuticals Reports Q1 Loss Per Share Of $0.55
08/05/2019 13:46
Brief: Allena Pharmaceuticals Says Axel Bolte Will Not Stand For Reelection At Annual Meeting
17/04/2019 13:15
Brief: Allena Pharmaceuticals Announces Agreement With Duke Clinical Research Institute For URIROX-2 Pivotal Phase 3 Trial
27/03/2019 12:17
Brief: Allena Pharmaceuticals Qtrly Net Loss Per Share $0.46
07/03/2019 13:06
NASDAQ RESUMED
09/01/2019 15:10
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE
09/01/2019 14:59
Brief: Allena Pharmaceuticals Appoints Louis Brenner As Chief Executive Officer
04/01/2019 13:42
Brief: Allena Pharma Achieves Alignment With FDA On Phase 3 Program For Reloxaliase
02/01/2019 13:13
Brief: Allena Pharmaceuticals Inc files for mixed shelf of upto $200 million - SEC filing
03/12/2018 21:40
Brief: Allena Pharmaceuticals reports third quarter results
07/11/2018 13:15
Brief: Allena Pharmaceuticals Reports Q2 Loss Per Share $0.42
07/08/2018 13:04
Brief: Allena Pharmaceuticals Inc - First Patients Treated In Phase 2 Basket Study Of ALLN-177
23/07/2018 13:17
Brief: Allena Pharmaceuticals Completes Animal Proof-Of-Concept Study For ALLN-346
19/06/2018 13:11